These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33537340)

  • 41. Abundance profiling of specific gene groups using precomputed gut metagenomes yields novel biological hypotheses.
    Yarygin K; Tyakht A; Larin A; Kostryukova E; Kolchenko S; Bitner V; Alexeev D
    PLoS One; 2017; 12(4):e0176154. PubMed ID: 28448616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A semi-tryptic peptide centric metaproteomic mining approach and its potential utility in capturing signatures of gut microbial proteolysis.
    Yan Z; He F; Xiao F; He H; Li D; Cong L; Lin L; Zhu H; Wu Y; Yan R; Li X; Shan H
    Microbiome; 2021 Jan; 9(1):12. PubMed ID: 33436102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex-Specific Effects of Organophosphate Diazinon on the Gut Microbiome and Its Metabolic Functions.
    Gao B; Bian X; Mahbub R; Lu K
    Environ Health Perspect; 2017 Feb; 125(2):198-206. PubMed ID: 27203275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Species Deletions from Microbiome Consortia Reveal Key Metabolic Interactions between Gut Microbes.
    Gutiérrez N; Garrido D
    mSystems; 2019 Jul; 4(4):. PubMed ID: 31311843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 46. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet?
    Knox NC; Forbes JD; Van Domselaar G; Bernstein CN
    Curr Treat Options Gastroenterol; 2019 Mar; 17(1):115-126. PubMed ID: 30661163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Propionate Fermentative Genes of the Gut Microbiome Decrease in Inflammatory Bowel Disease.
    Medina JM; Fernández-López R; Crespo J; Cruz F
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34070019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrinsic challenges in ancient microbiome reconstruction using 16S rRNA gene amplification.
    Ziesemer KA; Mann AE; Sankaranarayanan K; Schroeder H; Ozga AT; Brandt BW; Zaura E; Waters-Rist A; Hoogland M; Salazar-García DC; Aldenderfer M; Speller C; Hendy J; Weston DA; MacDonald SJ; Thomas GH; Collins MJ; Lewis CM; Hofman C; Warinner C
    Sci Rep; 2015 Nov; 5():16498. PubMed ID: 26563586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Robust Microbial Markers for Non-Invasive Inflammatory Bowel Disease Identification.
    Wingfield B; Coleman S; McGinnity TM; Bjourson AJ
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):2078-2088. PubMed ID: 29994028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis.
    Mancabelli L; Milani C; Lugli GA; Turroni F; Cocconi D; van Sinderen D; Ventura M
    FEMS Microbiol Ecol; 2017 Dec; 93(12):. PubMed ID: 29126267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analyzing Predominant Bacterial Species and Potential Short-Chain Fatty Acid-Associated Metabolic Routes in Human Gut Microbiome Using Integrative Metagenomics.
    Kingkaw A; Raethong N; Patumcharoenpol P; Suratannon N; Nakphaichit M; Keawsompong S; Roytrakul S; Vongsangnak W
    Biology (Basel); 2022 Dec; 12(1):. PubMed ID: 36671714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children.
    Gallardo-Becerra L; Cornejo-Granados F; García-López R; Valdez-Lara A; Bikel S; Canizales-Quinteros S; López-Contreras BE; Mendoza-Vargas A; Nielsen H; Ochoa-Leyva A
    Microb Cell Fact; 2020 Mar; 19(1):61. PubMed ID: 32143621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seasonal dynamics and starvation impact on the gut microbiome of urochordate ascidian Halocynthia roretzi.
    Wei J; Gao H; Yang Y; Liu H; Yu H; Chen Z; Dong B
    Anim Microbiome; 2020 Aug; 2(1):30. PubMed ID: 33499981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Presence of Genotoxic and/or Pro-inflammatory Bacterial Genes in Gut Metagenomic Databases and Their Possible Link With Inflammatory Bowel Diseases.
    Roche-Lima A; Carrasquillo-Carrión K; Gómez-Moreno R; Cruz JM; Velázquez-Morales DM; Rogozin IB; Baerga-Ortiz A
    Front Genet; 2018; 9():116. PubMed ID: 29692798
    [No Abstract]   [Full Text] [Related]  

  • 57. Identification of Specific Oral and Gut Pathogens in Full Thickness Colon of Colitis Patients: Implications for Colon Motility.
    Dinakaran V; Mandape SN; Shuba K; Pratap S; Sakhare SS; Tabatabai MA; Smoot DT; Farmer-Dixon CM; Kesavalu LN; Adunyah SE; Southerland JH; Gangula PR
    Front Microbiol; 2018; 9():3220. PubMed ID: 30666239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Moderate Exercise Has Limited but Distinguishable Effects on the Mouse Microbiome.
    Lamoureux EV; Grandy SA; Langille MGI
    mSystems; 2017; 2(4):. PubMed ID: 28845459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multi-Omics Reveals that Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites, and Metabolic Pathways.
    Gao B; Chi L; Mahbub R; Bian X; Tu P; Ru H; Lu K
    Chem Res Toxicol; 2017 Apr; 30(4):996-1005. PubMed ID: 28234468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.
    Ashton JJ; Colquhoun CM; Cleary DW; Coelho T; Haggarty R; Mulder I; Batra A; Afzal NA; Beattie RM; Scott KP; Ennis S
    Medicine (Baltimore); 2017 Jun; 96(26):e7347. PubMed ID: 28658154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.